Closing the medication loop after discharge
The medication loop reopens at discharge because every mechanism that closed it belongs to the hospital, and the patient no longer does. Closing it means re-establishing the two things the inpatient loop provided — an observation of what actually happened to the dose, and an escalation path when something went wrong — through contact with the patient rather than through instrumentation of a building.
Inside the hospital, closing the loop was an engineering problem. Outside it, it is a contact problem, which is why it stayed unsolved.
What exactly stops working at the door?
All of it, simultaneously, and this is worth sitting with rather than skipping past. The order is no longer visible to the hospital, so nobody knows if it was filled. The verification does not extend to what a community pharmacist substitutes. Nothing packages the dose, nothing releases it against a schedule, nothing scans it against the patient, and nothing writes back.
The patient walks out with a piece of paper and a set of instructions delivered to someone who has just been in hospital and is not at their most receptive. From the loop’s point of view, they have vanished.
A hospital that has invested heavily in closed-loop infrastructure has, at that moment, the same visibility into whether the medication is being taken as one that never bought any of it.
What would it take to close it?
Not a device. There is no barcode to scan in a patient’s kitchen and no realistic prospect of one that people would actually use — the history of adherence hardware is a long series of products that worked in a trial and were abandoned in month two.
The only mechanism that scales is asking. A structured contact at the points where medication failures surface, asking the questions that distinguish the four reasons people stop, capturing the answers as data rather than as a note, and routing the ones that need judgement to a clinician.
Which sounds simple and is arithmetically brutal. A few hundred discharges a week, several contacts each across thirty days, most calls unanswered on the first attempt, ten to fifteen minutes to conduct and document each answered one — performed by nurses and pharmacists, who are the scarcest resource in the building. That is why follow-up is rationed to the highest-risk decile everywhere, and the rationing is a correct allocation of a fixed resource rather than a clinical judgement that everyone else is fine.
Why does automation change the answer here specifically?
Because the constraint is volume rather than skill. The check-ins that catch a deteriorating patient are not difficult conversations — they are structured questions asked on a schedule, and the difficulty is that there are tens of thousands of them.
When the marginal cost of one more contact stops being a nurse-hour, the rationing stops being necessary. Contact everyone, structure the answers, and spend clinician time only on the cases where an answer crossed a threshold. The nurse’s day changes shape rather than shrinking: the dialling and documenting leave, and what arrives is a smaller number of patients who genuinely need a clinician, with the conversation already attached.
This is also where the inpatient loop pays a dividend that is easy to miss. A hospital that closed its inpatient loop knows exactly what the patient was actually given, dose by dose, up to the moment they left — which is a far better starting point for a post-discharge conversation than a discharge summary. The two halves are worth more joined than separately.
What does this not solve?
A patient who cannot afford their medication. Detecting that faster is genuinely useful and does not pay for anything. The contact surfaces the reason; somebody with a budget has to act on it.
An escalation nobody receives. Contacting the whole discharge population generates more escalations than contacting the top decile did — that is the point, and it is also a load. An organisation with no capacity to receive them has bought a more detailed view of a problem it still cannot fix. Plan the receiving end before the contacting end.
And it does not make the clinical decision. The agent collects and escalates; a clinician decides. A vendor describing software that decides whether a symptom matters is describing a regulated medical device, whether or not they have noticed.
Frequently asked
- Why does the medication loop reopen after discharge?
- Because every mechanism that closed it belongs to the hospital and the patient no longer does. Nothing confirms the prescription was filled, nothing packages or releases the dose against a schedule, nothing scans it against the patient, and nothing writes back. A hospital with extensive closed-loop infrastructure has the same visibility into whether a discharged patient is taking their medication as one that bought none of it.
- How do you close the medication loop after discharge?
- By re-establishing observation and escalation through contact with the patient rather than instrumentation of a building: a structured contact at the points where medication failures surface, questions that distinguish why someone stopped, answers captured as data rather than as a note, and clinical cases routed to a clinician. There is no device to scan in a patient’s kitchen, and the history of adherence hardware is a series of products abandoned in month two.
- Why is post-discharge follow-up rationed to high-risk patients?
- Arithmetic, not clinical judgement. A few hundred discharges a week with several contact attempts each, most unanswered on the first try, ten to fifteen minutes per answered call to conduct and document, performed by nurses and pharmacists — that is a very large number of hours from the scarcest resource in the building. Given a fixed number of hours, calling the highest-risk patients first is the correct allocation.